GlassScriptPhysician profile
Andrew Schupp
NPI 1861178436
$1,897.69
in general payments reported to CMS, 2019-2025
13 companies · $1,898 in 2025
The $1,898 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,898.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,100 · Long Term Medical Supply Or Device Loan: $798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,100.09 |
| Long Term Medical Supply Or Device Loan | $797.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $922.72 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $187.55 | 2025 | |
| Merck Sharp & Dohme LLC | $141.42 | 2025 | Keytruda, Welireg |
| Pfizer INC. | $139.36 | 2025 | |
| Celgene Corporation | $126.53 | 2025 | Reblozyl, Opdualag |
| Array Biopharma INC | $104.69 | 2025 | Mektovi, Braftovi, Tukysa |
| Legend Biotech USA INC. | $59.93 | 2025 | Carvykti |
| Takeda Pharmaceuticals U.S.A., INC. | $49.62 | 2025 | Alunbrig, Fruzaqla |
| Agios Pharmaceuticals, INC. | $46.99 | 2025 | Pyrukynd |
| Emd Serono, INC. | $43.18 | 2025 | |
| Sobi, INC | $30.18 | 2025 | |
| Geron Corporation | $25.52 | 2025 | Rytelo |
| Glaxosmithkline, LLC. | $20.00 | 2025 | Ojjaara |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Schupp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.